MARKET

BIORQ

BIORQ

BIORA THERAPEUTICS INC
OTCPK
0.135
0.000
0.00%
Closed 13:15 05/20 EDT
OPEN
0.135
PREV CLOSE
0.135
HIGH
0.135
LOW
0.118
VOLUME
30.57K
TURNOVER
3.96K
52 WEEK HIGH
7.90
52 WEEK LOW
0.080
MARKET CAP
610.56K
P/E (TTM)
-0.0115
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BIORQ last week (0512-0516)?
Weekly Report · 1d ago
Weekly Report: what happened at BIORQ last week (0505-0509)?
Weekly Report · 05/12 11:59
Weekly Report: what happened at BIORQ last week (0428-0502)?
Weekly Report · 05/05 12:02
Weekly Report: what happened at BIORQ last week (0421-0425)?
Weekly Report · 04/28 12:15
Weekly Report: what happened at BIORQ last week (0414-0418)?
Weekly Report · 04/21 12:14
Weekly Report: what happened at BIORQ last week (0407-0411)?
Weekly Report · 04/14 11:59
Weekly Report: what happened at BIORQ last week (0331-0404)?
Weekly Report · 04/07 11:59
Weekly Report: what happened at BIORQ last week (0324-0328)?
Weekly Report · 03/31 12:15
More
About BIORQ
Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and systemic, needle-free delivery of biotherapeutics. The Company’s pipeline includes two therapeutic delivery platforms: NaviCap and BioJet. The NaviCap, targeted oral delivery platform, which is designed to improve outcomes for patients with inflammatory bowel disease through treatment at the site of disease in the gastrointestinal tract. The BioJet, systemic oral delivery platform, which is designed to replace injection for better management of chronic diseases through needle-free, oral delivery of large molecules. It has two demonstration drug-device combination programs for the BioJet platform, BT-200 (GLP-1 receptor agonist) and BT-002 (adalimumab variant). Its other two programs include BT-600 (NaviCap + tofacitinib) and BT-001 (NaviCap + variant of adalimumab) for the treatment of ulcerative colitis.

Webull offers Biora Therapeutics Inc stock information, including OTCPK: BIORQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIORQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIORQ stock methods without spending real money on the virtual paper trading platform.